Abivax SA (ABVX)
87.00
-1.22
(-1.38%)
USD |
NASDAQ |
Oct 07, 16:00
87.95
+0.95
(+1.09%)
After-Hours: 20:00
Abivax Market Cap : 6.944B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 7.041B |
| October 05, 2026 | 7.322B |
| October 02, 2026 | 7.413B |
| October 01, 2026 | 7.591B |
| September 30, 2026 | 7.903B |
| September 29, 2026 | 7.862B |
| September 28, 2026 | 7.730B |
| September 25, 2026 | 7.268B |
| September 24, 2026 | 7.572B |
| September 23, 2026 | 7.513B |
| September 22, 2026 | 7.845B |
| September 21, 2026 | 8.257B |
| September 18, 2026 | 8.384B |
| September 17, 2026 | 8.540B |
| September 16, 2026 | 8.106B |
| September 15, 2026 | 8.457B |
| September 14, 2026 | 9.006B |
| September 11, 2026 | 9.407B |
| September 10, 2026 | 9.194B |
| September 09, 2026 | 9.472B |
| September 08, 2026 | 9.432B |
| September 04, 2026 | 9.102B |
| September 03, 2026 | 9.042B |
| September 02, 2026 | 8.808B |
| September 01, 2026 | 9.013B |
| Date | Value |
|---|---|
| August 31, 2026 | 8.859B |
| August 28, 2026 | 8.988B |
| August 27, 2026 | 9.063B |
| August 26, 2026 | 9.239B |
| August 25, 2026 | 9.351B |
| August 24, 2026 | 9.210B |
| August 21, 2026 | 9.115B |
| August 20, 2026 | 9.372B |
| August 19, 2026 | 9.559B |
| August 18, 2026 | 9.431B |
| August 17, 2026 | 9.573B |
| August 14, 2026 | 9.432B |
| August 13, 2026 | 9.630B |
| August 12, 2026 | 9.953B |
| August 11, 2026 | 10.05B |
| August 10, 2026 | 10.11B |
| August 07, 2026 | 10.38B |
| August 06, 2026 | 10.31B |
| August 05, 2026 | 9.942B |
| August 04, 2026 | 9.926B |
| August 03, 2026 | 9.894B |
| July 31, 2026 | 9.905B |
| July 30, 2026 | 9.858B |
| July 29, 2026 | 9.423B |
| July 28, 2026 | 9.850B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Poxel SA | 11.79M |
| OSE Immunotherapeutics SA | 99.33M |
| Cogent Biosciences, Inc. | 5.174B |
| Arrowhead Pharmaceuticals, Inc. | 8.677B |
| Oncolytics Biotech, Inc. | 74.16M |
Market Cap Related Metrics
| PEG Ratio | -0.0566 |
| Price to Book Value | 16.58 |
| Price | 87.00 |
| Earnings Yield | -7.02% |
| PEGY Ratio | -0.0566 |